跳至主要内容
临床试验/CTRI/2022/09/045789
CTRI/2022/09/045789尚未招募2 期

Prospective Clinical Study to Evaluate the Safety and Efficacy of theVersius Surgical System in Robot-Assisted Hysterectomy

CMR Surgical India Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient deemed suitable for total laparoscopic hysterectomy
  • procedure using Versius Surgical Robotic System
  • 2. Patients able to provide written informed consent to
  • participate in the study (with help of appropriate legal
  • representatives if required)
  • 3. Female, aged 18 years or above
  • 4. Female of childbearing potential, must not be pregnant
  • 5. Patients with BMI ââ?°Â¤40. Ideally BMI ââ?°Â¥25 to ââ?°Â¤ 40

排除标准

  • 1. Patient participation in an investigational clinical study within 30
  • days before screening
  • 2. Inability or difficulties to provide informed consent
  • 3. Oncological cases, patients undergoing surgery or treatment for
  • malignant disease
  • 4. Patients who fall into American Society of Anaesthesiologists (ASA)
  • Class IV or above (Appendix B)
  • 5. Uterus size of > 14 weeks
  • 6. History of chronic alcohol or drug abuse
  • 7. Chronic renal failure or on dialysis
  • 8. Significant medical history or immunocompromised
  • 9. Subjects with any other clinically significant unstable medical
  • disorder, life-threatening disease, or anything else in the opinion
  • of the Investigator which would contra-indicate a surgical procedure
  • 10. Patient tested COVID positive within last 30 days of screening
  • 11. Patient tested COVID positive within 48 hours within procedure
  • 12. Diabetes mellitus (Glycemia > 11mmol/L; >200 mg/dL)
  • 13. Uncontrolled hypertension

研究者

发起方
CMR Surgical India Pvt Ltd

相似试验